Showing results (351-360 of 7,002) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|September 1, 2019
A case of invasive mucinous adenocarcinoma of the lung showing stepwise progression at the primary siteHitomi Kawai, Masato Sugano, Noriyuki Nakano, et al.
Lung Cancer (Amsterdam, Netherlands)|September 4, 2019
A case of primary lung squamous cell carcinoma mimicking malignant mesothelioma producing granulocyte colony stimulating factor with chemotherapy (cisplatin and gemcitabine)-associated thrombotic thrombocytopenic purpura (TTP); An autopsy case reportYasuhito Suzuki, Kenya Kanazawa, Risa Kanai, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2019
Galectin-9 in non-small cell lung cancerYayi He, Keyi Jia, Rafal Dziadziuszko, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2022
Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2)Wei Zhang, Pengbo Deng, Tiandong Kong, et al.
Lung Cancer (Amsterdam, Netherlands)|October 5, 2022
Machine learning-based exceptional response prediction of nivolumab monotherapy with circulating microRNAs in non-small cell lung cancerYifan Zhang, Yasushi Goto, Shigehiro Yagishita, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2022
Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case reportOlfa Trabelsi Grati, Leila Zemoura, Caroline Nhy, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2022
Prevalence and breakdown of non-small cell lung cancer BRAF driver mutations in a large UK cohortGuan Hui Tricia Lim, Kevin Jon Balbi, Benjamin Poskitt, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2021
Revealing the BRD4-NOTCH3 fusion: A novel hill in the cancer landscapeFabiano de Almeida Costa, Mariane Tami Amano, Paula Fontes Asprino, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2019
Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lungMoonsik Kim, Yeon Seung Chung, Kyoung A Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2019
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancerBenjamin Besse, Fabrice Barlesi, Ingel Demedts, et al.
Pageof 701